The Organ Preservation Device Market is witnessing robust growth as hospitals and transplant centers focus on improving organ viability and transplant outcomes. Valued at USD 1.4 billion in 2024, the market is projected to reach USD 6.5 billion by 2035, expanding at a CAGR of 14.9% from 2025 to 2035. Rising organ transplant procedures, increasing prevalence of end-stage organ failures, and technological advancements are driving adoption globally.
Market Drivers
Increasing organ transplant volumes due to rising chronic diseases such as liver failure, kidney failure, and cardiovascular disorders are boosting demand. Regulatory guidelines mandating the use of preservation solutions and devices to maintain organ quality are supporting market growth. Moreover, advancements in portable and normothermic perfusion devices enhance the viability and transportation of organs, expanding the reach of transplant programs.
Opportunities and Trends
Growing adoption of machine perfusion devices to improve long-term transplant outcomes.
Expansion in heart, liver, kidney, and lung transplants worldwide.
Research initiatives for improved preservation solutions.
Increasing focus on reducing organ discard rates through innovative preservation techniques.
Regional Insights
North America dominates due to advanced healthcare infrastructure and high organ transplantation rates.
Europe has strong regulatory frameworks supporting device adoption.
Asia-Pacific shows rapid growth with increasing organ transplant programs and awareness.
South America and MEA are emerging markets with rising investments in transplantation facilities.
Competitive Landscape
The market is highly competitive with key players such as TransMedics, Organ Recovery Systems, and Bridge to Life investing in R&D, partnerships, and expanding regional presence. Companies are focusing on device automation, portability, and efficiency to gain a competitive edge.